Compounds > metoprolol
Page last updated: 2024-10-31

metoprolol and Encephalopathy, Hepatic

metoprolol has been researched along with Encephalopathy, Hepatic in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uribe, M1
Orozco, H1
Morán, S1
Guevara, L1
Poo, JL1
Vargas-Vorackova, F1

Trials

1 trial available for metoprolol and Encephalopathy, Hepatic

ArticleYear
Portal-systemic encephalopathy and gastrointestinal bleeding after cardioselective beta-blocker (metoprolol) administration to patients with portal hypertension.
    Archives of medical research, 1995,Autumn, Volume: 26, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Gastrointestinal Hemorrhage; Hepatic Encephalo

1995